Translational Medicine and Bioengineering Conference

November 12-13, 2016

Presented by the Society of Biological Engineering (SBE), this conference will bring together leaders and trainees from cutting edge fields of Translational Medicine and Bioengineering. 

This inaugural Translational Medicine and Bioengineering Conference will bring together researchers and practitioners focused on the development and the clinical and commercial translation of biological technologies. The conference will feature cutting edge advances in the translation of biopharmaceuticals, gene and drug delivery, immunoengineering, biomanufacturing, stem cells and regenerative medicine and entrepreneurship in a single-track conference format.

Conference Chairs:

  • Ravi Kane, Georgia Institute of Technology
  • Mark Prausnitz, Georgia Institute of Technology 

Keynote and Invited Speakers:

  • David Schaffer, University of California, Berkeley
  • Sean Palecek, University of Wisconsin–Madison
  • Karl Dane Wittrup, Massachusetts Institute of Technology
  • Chaitan Khosla, Stanford University
  • Jennifer Cochran, Stanford University
  • Savas Tay, University of Chicago
  • Jordan Green, Johns Hopkins University
  • Sandeep Kumar, Pfizer

Entrepreneurship Panel Participants

  • Samir Mitragotri, University of California, Santa Barbara
  • Katharine Ku, Stanford University
  • Mark E. Davis, California Institute of Technology
  • Krishnendu Roy, Georgia Institute of Technology
  • Grace Colon, New Science Venture
  • Josh Vose, Medtronic Advance Energy

Sessions:

  • Biopharmaceuticals

    • Session Chair: Casim Sarkar, University of Minnesota Twin Cities
    • Session Chair: Pete Tessier, Rensselaer Polytechnic Institute
  • Gene and Drug Delivery

    • Session Chair: Pankaj Karande, Rensselaer Polytechnic Institute
    • Session Chair: Millicent Sullivan, University of Delaware
  • Immunoengineering

    • Session Chair: Susan Thomas, Georgia Institute of Technology
    • Session Chair: Julie Champion, Georgia Institute of Technology
  • Biomanufacturing

    • Session Chair: Hyunmin Yi, Tufts University
    • Session Chair: Cynthia Collins, Rensselaer Polytechnic Institute 
  • Stem Cells/ Regenerative Medicine

    • Session Chair: Rebecca Carrier, Northeastern University
    • Session Chair: Krishanu Saha, University of Wisconsin–Madison
  • Translation (VC, IP, regulatory, business)

    • Session Chair: David Putnam, Cornell University
    • Session Chair: Kaushal Rege, Arizona State University

Featured Speakers

Jennifer R. Cochran

Jennifer Cochran, Ph.D., is the Shriram Chair of Bioengineering and is an Associate Professor of Bioengineering, and, by courtesy, of Chemical Engineering at Stanford University. Formerly the Director of Graduate Studies in Bioengineering, she currently serves as the Director of the Stanford-NIH Biotechnology Predoctoral Training Grant, and Co-Director of the Stanford-NIST Graduate Training Program. Her research group uses interdisciplinary approaches in chemistry, engineering, and biophysics to study complex biological systems and to develop new technologies for basic science and biomedical applications. She has received the National Cancer Institute Howard Temin Award, the Martin D. Abeloff Scholar Award from the V Foundation for Cancer Research, an American Cancer Society Research Scholar Award, and a Sidney Kimmel Scholar Award. She was also named the 47th Mallinckrodt Faculty Scholar by the Edward Mallinckrodt Jr. Foundation.Read more

Grace Colón

Dr. Grace E. Colón has over 25 years of experience in biopharma, genomics, diagnostics, health care and industrial biotechnology, in both strategic and operational roles with leading public and private companies and as a management consultant at McKinsey.  Her executive roles have spanned a broad range of functions, including corporate development/alliance management, commercial strategy and R&D.   She is currently a partner at New Science Ventures, a New York-based venture capital firm with $400M under management invested in life science and information technology...Read more

Chaitan Khosla

Research interests in this laboratory lie at the interface between chemistry and biology. Assembly line enzymes such as polyketide synthases have extraordinary potential for the programmable biosynthesis of complex natural products. Our laboratory seeks to understand the mechanistic logic of assembly line polyketide synthases, and to harness these insights in order to engineer new antibiotics. The prototypical system of interest to us is the 6-deoxyerythronolide B synthase, which synthesizes the macrocyclic core of erythromycin. Other examples of antibiotic biosynthetic pathways under...Read more

Katharine Ku

Katharine Ku is Executive Director of the Office of Technology Licensing (OTL) at Stanford University.  OTL is responsible for the licensing of various state-of-the-art university technologies and industry sponsored research agreements, material transfer agreements and collaborations.  In FY 2015, OTL received $95.1M in gross royalty revenue from over 695 technologies.

Ku was Vice President, Business Development at Protein Design Labs, Inc. from 1990-1991.  Prior to Stanford and PDL, Ku was a researcher at Monsanto and Sigma Chemical, and taught chemistry.

...Read more

Samir Mitragotri

Dr. Samir Mitragotri is the Hiller Professor of Bioengineering at the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) and is also appointed as the Wyss Professor of Biologically Inspired Engineering at Harvard’s Wyss Institute.
Professor Mitragotri received Ph.D. from MIT in 1996 and B.S. from the Institute of Chemical Technology, Mumbai in 1992, both in Chemical Engineering.Read more

Sean Palecek

Sean Palecek is the Milton J. and Maude Shoemaker Professor and a Vilas Distinguished Achievement Professor in the Department of Chemical & Biological Engineering at the University of Wisconsin – Madison.  Sean received a bachelor’s degree in chemical engineering at the University of Delaware.  He performed his graduate research with Doug Lauffenburger and Rick Horwitz, earning an M.S. in chemical engineering from the University of Illinois at Urbana-Champaign and a Ph.D. in chemical engineering from MIT.  Sean performed postdoctoral research in molecular genetics and...Read more

David Schaffer

David Schaffer is a Professor of Chemical and Biomolecular Engineering, Bioengineering, and Neuroscience at University of California, Berkeley, where he also serves as the Director of the Berkeley Stem Cell Center.Read more

Savas Tay

Savas Tay is a systems biologist and bioengineer who works at the interface of biology, physics, and engineering. His overarching goal is to understand how biological systems work from an engineer’s perspective, and use this knowledge to manipulate cells and gene pathways to help cure diseases. On the technology front, his lab develops high-throughput and high-content single-cell analysis devices by integrating microfluidics and optics.

Prof. Tay is joining University of Chicago as an Associate Professor in the summer of 2016 from ETH Zurich in Switzerland. A main focus for...Read more

K Dane Wittrup

Professor K. Dane Wittrup is the Carbon P. Dubbs Professor of Chemical Engineering and Biological Engineering at the Massachusetts Institute of Technology, a position he has held since 1999. From 1989-1999 he was Assistant Professor, Associate Professor, and then J. W. Westwater Professor of Chemical Engineering, Bioengineering, and Biophysics at the University of Illinois in Champaign/Urbana.

Prof. Wittrup received a B.S. in Chemical Engineering Summa cum Laude in 1984 from the University of New Mexico, and a Ph.D. in Chemical Engineering from the California Institute of Technology...Read more

Proceedings

Proceedings of the Translational Medicine and Bioengineering Conference are now available: